Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

25 August 2016

F‐star Announces Collaborative Agreement with Denali Therapeutics for the  Development of a Multispecific Antibody Platform to Deliver Therapeutics  Across the Blood‐Brain Barrier.More

2 March 2016

miRagen Therapeutics Initiates First Clinical Trial for MRG-106 in Lymphoma Patients.More

29 February 2016

Thrasos Announces Promising Results for Phase 2 THR-184 Dose Ranging Clinical Study for the Prevention of Acute Kidney Injury (AKI).More

11 January 2016

F-star Enters into Collaborative Discovery & Development Agreement with AbbVie for Bispecific Antibodies in Immuno-oncology. More

10 November 2015

miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials.More


Featured Portfolio